A look at the following clinical trial: Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian Cancer
A look at the following clinical trial: A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer
A look at the following clinical trial: Screening Methods for Finding Ovarian Cancer
A look at the following clinical trial: Study of Individuals and Families at High Risk for Breast or Ovarian Cancer
A look at the following clinical trial: M. D. Anderson Symptom Inventory – Ovarian Cancer
Provides information to potential participants on the following clinical trial: A Phase II Study of the Synergistic Interaction of Lovastatin and Paclitaxel For Patients With Refractory or Relapsed Ovarian Cancer
Provides information to potential participants on the following clinical trial: An Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian Cancer
Provides information to potential participants on the following clinical trial: A Phase 1b, Parallel Arm, Multicenter, Open-Label Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Two Different Chemotherapy Regimens in Women With Platinum Resistant or Platinum Sensitive Ovarian Cancer
Provides information to potential participants on the following clinical trial: A Phase 1, Open-label, Multi-center, Dose Escalation Study of the Safety and Pharmacokinetics of AGS-8M4 Given as Monotherapy in Subjects With Advanced Ovarian Cancer
Provides information to potential participants on the following clinical trial: AZD2281 and Carboplatin in Treating Patients With BRCA1/BRCA2-Associated, Hereditary, or Triple Negative Metastatic or Unresectable Breast Cancer or Ovarian Epithelial Cancer
Please login or register first to view this content.
